Bladder cancer: Pioglitazone-when is a prescription drug safe?

Research output: Contribution to journalAbstractpeer-review

1 Citation (Scopus)

Abstract

In a recent issue of JAMA, Lewis et al. present long-term data on the likelihood of a link between pioglitazone and the risk of bladder cancer and ten other cancers. Their findings contradict previous concerns regarding the safety of pioglitazone, and add to the controversy surrounding interpretation of rare adverse events associated with prescription drugs.
Original languageEnglish
Pages (from-to)655-656
Number of pages2
JournalNature Reviews Urology
Volume12
Early online date29 Sep 2015
DOIs
Publication statusPublished - 2015

Keywords

  • Bladder cancer
  • Diabetes
  • Drug safety

Cite this